Verneuil Vanina De
General Counsel at Vir Biotechnology, Inc. (VIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $218K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 3,117126,682 held (−2%) | $9.53 | $30K | +22.8% |
| Feb 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 13,700112,982 held (−11%) | $9.82 | $135K | +19.1% |
| Feb 24SEC | VIRVir Biotechnology, Inc. | Sell Plan | 4,445129,799 held (−3%) | $7.45 | $33K | +57.0% |
| Nov 7SEC | VIRVir Biotechnology, Inc. | Sell Plan | 2,38578,210 held (−3%) | $5.16 | $12K | +126.7% |
| Nov 4SEC | VIRVir Biotechnology, Inc. | Sell Plan | 1,36580,595 held (−2%) | $5.86 | $8K | +99.7% |
- Sell
General Counsel Verneuil Vanina De sold $30K of VIR at $9.53 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Verneuil Vanina De sold $135K of VIR at $9.82 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Verneuil Vanina De sold $33K of VIR at $7.45 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Verneuil Vanina De sold $12K of VIR at $5.16 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Verneuil Vanina De sold $8K of VIR at $5.86 — pre-scheduled 10b5-1 plan sale.